Skip redundant pieces
KU Home  :  Pharmacy Practice  :  Pharmacy Practice Faculty

David Henry

Associate Professor and Interim Chair
Email: dhenry@kumc.edu
Phone Numbers:
913-588-5373 (Medical Center Campus)
785-864-6066 (Lawrence Campus)

Educational Background

BS Pharm and MS Hospital Pharm, KU

Brief Biography

My practice area for the last 25 years has been the Pediatric Hematology/Oncology service at the University of Kansas Hospital. I have been very active in the Pediatric Oncology Group (before 2000), and the Children’s Oncology Group (after 2000). I am currently on the BPS Oncology Specialty Council that oversees development of the BCOP exam.

I teach a Peds Heme/Onc clerkship rotation, Oncology Pharmacotherapy in the Pharmacotherapy sequence, Oncology drugs in the Pharmacokinetics course, an Advanced Oncology Pharmacy elective, and some basic Pharmacy topics in a course that covers drug interactions, monitoring drug therapy, and non-prescription medications.

Outside of work, I enjoy watching and participating in sports. My favorite vacation activity is hiking in the mountains.

Research Interests

Treatment of bone and soft tissue sarcomas in pediatric and young adult patients; anti-cancer agent dosing in obese patients; and nutrition and cancer treatment. In the past, I have been active studying stability of drugs in extemporaneous formulations.

Publications

  • Cohen MS, Al-kasspooles MF, Williamson SK, Henry D, Broward M, Roby KF. Combination intraperitoneal chemotherapy is superior to mitomycin C or oxaliplatin for colorectal carcinomatosis in vivo. Ann Surg Oncol 2009; Online Aug 26th DOI 10.1245/s10434-009-0669-0.
  • Kettle JK, Finkbiner KL, Klenke SE, Baker RD, Henry DW, Williams CB. Initial therapy in multiple myeloma: investigating the new treatment paradigm. J Oncol Pharm Practice 2009;15;131-141.
  • Henry DW. Pediatric cancers. In Finley RS, Balmer C. Concepts in Oncology Therapeutics. 3rd edition, ASHP (submitted, to be published in 2009)
  • Goodin S, Henry DW. Solid Tumors (pediatrics section). In Koda-Kimble MA, Young LY, Alldredge BK, et al. Applied Therapeutics: The Clinical Use of Drugs. Lippincott, Williams & Wilkins. Philadelphia. 9th edition. 2009. pp. 91-22 to 91-30.
  • Butturini AM, Dorey FJ, Lange BJ, Henry DW, Gaynon PS, Fu C, Franklin J, Siegel S, Seibel N, Rogers PC, Sather H, Trigg M, Bleyer WA, Carroll W. Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 2007;25:2063-2069.
  • Ladas EJ, Sacks N, Meacham L, Henry D, Enriquez L, Lowry G, Hawkes R, Dadd G, Rogers P. A multidisciplinary review of nutrition considerations in the pediatric oncology population: a perspective from the Children’s Oncology Group. Nutrition in Clinical Practice 2005;20:377-393.
  • Rogers PC, Meacham LR, Oeffinger KC, Henry DW, Lange BJ. Obesity in pediatric oncology. Pediatric Blood and Cancer 2005;45:881-891.